Navigation Links
Ex-Convicts From Tobacco-Free Prisons Need Help to Stay Off Smokes
Date:4/10/2013

WEDNESDAY, April 10 (HealthDay News) -- Inmates who quit smoking while in smoke-free prisons are more likely to stay tobacco free if they receive special counseling before they're released, new research suggests.

Interventions based on motivational interviewing and behavioral therapy improve smoking cessation rates among ex-convicts, according to a study published April 8 in the journal JAMA Internal Medicine.

The study, led by Dr. Jennifer Clarke, of Memorial Hospital of Rhode Island, involved nearly 300 inmates scheduled for release from a smoke-free prison in roughly eight weeks. Of the participants, 35 percent were women.

Each participant was randomly assigned to receive six weekly sessions of education videos or a behavioral intervention known as the WISE intervention (Working Inside for Smoking Elimination).

Three weeks after they were released from prison, 25 percent of the inmates assigned to the WISE intervention group remained tobacco free. In contrast, only 7 percent of those in the educational video group continued their smoking cessation, according to a journal news release.

The inmates who were smoke-free early on were reassessed at three months. By this point, 12 percent of the inmates from the WISE group and 2 percent of the educational video group remained tobacco-free.

Inmates who were Hispanic, who had a plan to avoid smoking and who had been in prison for more than six months were more likely to succeed in their attempt to stop smoking.

The study received funding from the U.S. National Institutes of Health/National Institute on Drug Abuse.

More information

The U.S. Centers for Disease Control and Prevention has more about tobacco use and smoking.

-- Mary Elizabeth Dallas

SOURCE: JAMA Internal Medicine, news release, April 8, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ex-Convicts From Tobacco-Free Prisons Need Help to Stay Off Smokes
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: